Keywords: Shire, Sangamo BioSciences, Hemophilia, Monogenic diseases, Licensing

Shire partners with Sangamo for hemophilia and other diseases

Article | 02 February 2012

Print This

Ireland-headquartered specialty pharma company Shire plc (LSE: SHP) has entered into a collaboration and licensing agreement with the USA’ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in